SOPHARMA: strona spółki
20.04.2026, 12:55
SPH Notification for sales revenues for March 2026
Sofia, Bulgaria, April 20, 2026 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that March 2026 the Company recorded an increase in sales of 14% compared to the same month of the previous year, incl. 25% decrease in domestic sales and 29% increase in export sales.
For the period from the beginning of 2026, the Company achieved sales growth of 10%, including a 32% decrease in domestic sales and a 33% growth in export sales.
For the period from the beginning of 2026, the Company achieved sales growth of 10%, including a 32% decrease in domestic sales and a 33% growth in export sales.